Clinical Trials Browser

Phase 1/2 × OTHER × gedatolisib × Clear all

NCT03911973 2024-06-07

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms

NCT03400254 2020-04-28

GLACIER

Phase 1/2 Withdrawn

Breast Neoplasms

NCT02920450 2019-10-04

UF-STO-LUNG-002

Phase 1/2 Terminated

3 enrolled 8 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung